Kucharska-Newton Anna M, Couper David J, Pankow James S, Prineas Ronald J, Rea Thomas D, Sotoodehnia Nona, Chakravarti Aravinda, Folsom Aaron R, Siscovick David S, Rosamond Wayne D
Cardiovascular Disease Epidemiology, Department of Epidemiology, University of North Carolina at Chapel Hill, 137 E Franklin St, Suite 306, Chapel Hill, NC 27514, USA.
Arterioscler Thromb Vasc Biol. 2009 Dec;29(12):2182-90. doi: 10.1161/ATVBAHA.109.192740. Epub 2009 Oct 1.
This study examines the hypothesis that chronic inflammation is associated with a higher risk of cardiac death compared to the risk of nonfatal myocardial infarction.
Cardiac death and nonfatal MI events were identified in the ARIC cohort during follow-up from 1987 through 2001. Markers of inflammation and hemostasis were determined at baseline using standardized procedures. Cox proportional hazard regression and polytomous logistic regression were used to estimate associations. We observed a positive gradient in incidence of sudden cardiac death (SCD), nonsudden cardiac death (NSCD), and nonfatal MI in association with decreasing levels of albumin and increasing levels of white blood cell count and of markers of hemostasis (fibrinogen, von Willebrand factor, factor VIIIc). Associations for von Willebrand factor were stronger for fatal relative to nonfatal events (3rd versus 1st tertile hazard ratios: SCD 3.11 [95% CI 2.10, 4.59], NSCD 2.12 [95% CI 1.28, 3.49], nonfatal MI 1.42 [95% CI 1.19, 1.70]). For factor VIIIc those associations were strongest for sudden cardiac death: SCD 3.16 (95% CI 2.18, 4.58), NSCD 1.44 (95% CI 0.93, 2.24), nonfatal MI 1.54 (95% CI 1.29, 1.84). Gradients of association for fibrinogen and white blood cell count, examined over tertiles of distribution and per one SD increase, were similar for the 3 end points. All associations were independent of smoking status.
von Willebrand factor and factor VIIIc are associated with an increased risk of cardiac death as compared to the risk of nonfatal MI.
本研究检验以下假设,即与非致命性心肌梗死风险相比,慢性炎症与心脏性死亡风险更高相关。
在1987年至2001年的随访期间,在动脉粥样硬化风险社区(ARIC)队列中确定了心脏性死亡和非致命性心肌梗死事件。在基线时使用标准化程序测定炎症和止血标志物。采用Cox比例风险回归和多分类逻辑回归来估计相关性。我们观察到,随着白蛋白水平降低以及白细胞计数和止血标志物(纤维蛋白原、血管性血友病因子、凝血因子VIIIc)水平升高,心源性猝死(SCD)、非心源性猝死(NSCD)和非致命性心肌梗死的发生率呈正梯度变化。血管性血友病因子与致命事件的相关性强于非致命事件(第三分位数与第一分位数风险比:SCD为3.11[95%可信区间2.10,4.59],NSCD为2.12[95%可信区间1.28,3.49],非致命性心肌梗死为1.42[95%可信区间1.19,1.70])。对于凝血因子VIIIc,这些相关性在心源性猝死中最强:SCD为3.16(95%可信区间2.18,4.58),NSCD为1.44(95%可信区间0.93,2.24),非致命性心肌梗死为1.54(95%可信区间1.29,1.84)。纤维蛋白原和白细胞计数的相关性梯度,在分布的三分位数范围内以及每增加一个标准差进行检验时,这3个终点相似。所有相关性均独立于吸烟状态。
与非致命性心肌梗死风险相比,血管性血友病因子和凝血因子VIIIc与心脏性死亡风险增加相关。